Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Graupera

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort studyKatrine P Lindvig, Katrine H Thorhauge, Johanne K Hansen, et al.
Hepatology (Baltimore, Md.)|September 19, 2021
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseasesPere Ginès, Laurent Castera, Frank Lammert, et al.
Lancet (London, England)|December 10, 2019
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialZobair M Younossi, Vlad Ratziu, Rohit Loomba, et al.
JHEP Reports : Innovation in Hepatology|September 22, 2025
Autoantibodies are associated with worse outcomes in MASLDAnna Soria, Alba Díaz, Paula Iruzubieta, et al.
Gut|October 26, 2023
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysisAdrià Juanola, Ann Thu Ma, Koos de Wit, et al.
Hepatology (Baltimore, Md.)|September 2, 2021
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitisRichard Taubert, Bastian Engel, Jana Diestelhorst, et al.
JHEP Reports : Innovation in Hepatology|September 13, 2023
Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver diseaseCelia Martínez-Sánchez, Octavi Bassegoda, Hongping Deng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 11, 2026
Hepatic venous pressure gradient, non-invasive tests, and prognosis across the subtypes of advanced steatotic liver diseaseBenedikt S Hofer, Sarah Shalaby, Wilhelmus Kwanten, et al.
JHEP Reports : Innovation in Hepatology|December 1, 2025
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort studyAdrià Juanola, Gabriel Mezzano, Elisa Pose, et al.
Cell Death & Disease|August 10, 2023
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosisKang Zheng, Fengjie Hao, Sandra Medrano-Garcia, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort studyKatrine P Lindvig, Katrine H Thorhauge, Johanne K Hansen, et al.
Hepatology (Baltimore, Md.)|September 19, 2021
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseasesPere Ginès, Laurent Castera, Frank Lammert, et al.
Lancet (London, England)|December 10, 2019
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialZobair M Younossi, Vlad Ratziu, Rohit Loomba, et al.
JHEP Reports : Innovation in Hepatology|September 22, 2025
Autoantibodies are associated with worse outcomes in MASLDAnna Soria, Alba Díaz, Paula Iruzubieta, et al.
Gut|October 26, 2023
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysisAdrià Juanola, Ann Thu Ma, Koos de Wit, et al.
Hepatology (Baltimore, Md.)|September 2, 2021
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitisRichard Taubert, Bastian Engel, Jana Diestelhorst, et al.
JHEP Reports : Innovation in Hepatology|September 13, 2023
Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver diseaseCelia Martínez-Sánchez, Octavi Bassegoda, Hongping Deng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 11, 2026
Hepatic venous pressure gradient, non-invasive tests, and prognosis across the subtypes of advanced steatotic liver diseaseBenedikt S Hofer, Sarah Shalaby, Wilhelmus Kwanten, et al.
JHEP Reports : Innovation in Hepatology|December 1, 2025
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort studyAdrià Juanola, Gabriel Mezzano, Elisa Pose, et al.
Cell Death & Disease|August 10, 2023
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosisKang Zheng, Fengjie Hao, Sandra Medrano-Garcia, et al.
Pageof 11